Doctoral Dissertation Defense | Jennifer Chavez
About this Event
11200 SW 8th ST, Academic Health Center 5, Miami, Florida 33199
UNIVERSITY GRADUATE SCHOOL BULLETIN
ANNOUNCEMENT
Florida International University
University Graduate School
Doctoral Dissertation Defense
Abstract
Probing the Proteome: Depressive Symptoms, Inflammation & Mitochondrial Perturbations in Acute HIV Infection
by
Jennifer Vanessa Chavez
There is ample evidence that HIV-associated pathophysiologic alterations fuel neuropsychiatric comorbidities.
During acute HIV infection (AHI) damage to the gut-associated lymphoid tissue causes translocation of microbial
products, including lipopolysaccharides, and drives gut-immune dysfunction. Even though antiretroviral therapy (ART)
suppresses viral replication, it fails to completely restore gut barrier integrity and normalize plasma immune markers,
driving chronic immune activation and inflammation. This proinflammatory state is made worse by a marked reduction in
antioxidants and upregulation of ROS and/or reactive nitrogen species, affecting mitochondrial function. Additionally,
substance use also increases HIV pathogenesis in the central nervous system (CNS) despite ART.
Proteomics, the evaluation of the function and structure of proteins to understand an organism’s nature, has been
leveraged to examine HIV-associated outcomes across the lifespan. However, much of the existing literature has focused
on individuals with chronic, treated HIV infection, making it challenging to disentangle the biological processes initiated
by HIV itself from the compounded effects of chronic infection, prolonged ART use, aging and comorbid conditions.
Examining the earliest stages of HIV infection provides a unique opportunity to characterize initial neuroimmune events
that may precede long-term neuropsychiatric complications, like depressive symptoms.
Therefore, the overarching goal of this dissertation is to examine how peripheral molecular processes beyond
inflammation and immune activation, including immunometabolic, lipid and systemic metabolism, mitochondrial and
neuroendocrine mechanisms, during AHI may contribute to depressive symptoms and concurrent brain volumetrics among
PWH. To accomplish this, baseline sociodemographic, clinical, and substance use data as well as plasma samples from the
RV254/SEARCH010 cohort, one of the largest cohorts of individuals undergoing extensive clinical phenotyping in
Bangkok, Thailand from acute through chronic HIV, were leveraged. In paper 1, we characterized individuals within the
cohort across machine learning derived depressive symptom trajectories. In paper 2, we attempt to understand the
biological mechanisms underlying depressive symptom trajectories through targeted proteomic analyses. In paper 3, we
attempt to understand if these biological mechanisms extend to the brain, and identify proteomic signatures associated
with concurrent brain volumetrics. Together, these studies combine clinical, molecular and neuroimaging data to improve
our understanding of biological processes linking AHI to long-term neuropsychiatric outcomes.
Department: Environmental Health Sciences
Major Professor: Dr. Adam W. Carrico
Date: November 10, 2026
Time: 10:30 a.m.
Place: MMC, AHC5-401
Zoom Information:
https://fiu.zoom.us/j/89819741243?pwd=YaVJbbJ6qBkbaC
Xr8OQcnYMk2bB3iM.1
Meeting ID: 898 1974 1243
Passcode: Ks79zK
Event Details
See Who Is Interested
0 people are interested in this event
User Activity
No recent activity